Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
30.75
+0.83 (2.77%)
Sep 4, 2026, 4:00 PM EDT - Market closed

Tectonic Therapeutic Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
601390681---
Market Cap Growth
96.79%-42.68%----
Enterprise Value
378123525---
Last Close Price
30.7520.8646.17---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.641.554.84---
P/TBV Ratio
2.691.554.84---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.010.02-1.080.170.04
Net Debt / Equity Ratio
-0.99-1.00-0.986.09-0.86-0.98
Net Debt / EBITDA Ratio
2.383.062.450.570.951.77
Net Debt / FCF Ratio
3.084.192.330.601.011.85
Quick Ratio
21.9026.2612.170.704.596.82
Current Ratio
22.2926.6312.650.764.736.95
Return on Equity (ROE)
-33.80%-37.82%-84.79%-276.60%-102.77%-
Return on Assets (ROA)
-22.29%-25.38%-37.71%-64.44%-51.24%-
Return on Capital Employed (ROCE)
-41.90%-33.40%-41.10%2998.50%-83.40%-54.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-14.27%-18.99%-8.51%---
FCF Yield
-12.05%-15.44%-8.70%---
Buyback Yield / Dilution
-14.76%-115.81%-569.30%49.78%--
SEC Filings: 10-K · 10-Q